Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Five Things That Owners and Boards Need to Know About Privacy and Cybersecurity Compliance

Client Alert

Do you serve on a Board of Directors or serve in a similar advisory capacity for a company or organization? Do you own your own business? Here are five things you should know about privacy and cybersecurity compliance.

  1. Upholding Your Fiduciary Duties

As a fiduciary of an organization, you may already know that you have a duty of loyalty and duty of care, including the duty to keep investors and owners informed of the cybersecurity risks of the organization. You also have the duty to protect the organization from undue risk, balancing the organization’s ability to conduct its operations with appropriate levels of risk mitigation strategies.

  1. Basic Knowledge of Privacy and Cybersecurity Issues

To properly fulfill your fiduciary duties, you need to obtain and maintain a basic knowledge of cybersecurity and privacy issues and risks facing the organization. Lack of understanding is not an excuse, and it is expected that Boards familiarize themselves with the cybersecurity efforts in the organization, champion and drive the organization’s commitment to ensure adequate cybersecurity protections are established and maintained. Board members and owners are also strongly encouraged to engage in the organization’s training and awareness campaigns and gain additional awareness as it relates to advising organizations effectively.

  1. Maintain the Company’s Reputation and Public Perception

Privacy and cybersecurity compliance builds the foundation of trust and reinforces an organization’s reputation for honoring the privacy expectations of both customers and business partners. A company’s character and brand are driven by industry expectations, treatment of customer data, legal requirements and product development. Mishandling a security breach can have devastating effects on the organization’s reputation, financial, operational and other aspects of the business. Many companies do not recover from a data breach due to the lack of proper advance planning and proper oversight.

  1. Watchdogs

In the United States alone, there are several different government authorities that maintain varying levels and scopes of authority over organizations with respect to privacy and cybersecurity issues, including the Securities and Exchange Commission, Federal Trade Commission, Department of Justice, Federal Sentencing Commission, and State Attorneys General, to name a few. There are also non-governmental watchdogs, from privacy advocacy groups who lobby for stricter laws and regulations and plaintiffs’ attorneys who bring actions against organizations that fail to comply with laws and regulations as well as organizations’ own stated privacy practices.

  1. Board Personal Liability

Breaches of fiduciary duties can be a slippery slope: subjecting board members to personal liability if the failure to exercise a minimum level of care, such as ignoring cybersecurity risks of the organizations, delegating responsibility without oversight, and lack of proper skill or training to properly advise the organization in these matters. Penalties can range from debarment from eligibility to bid on future federal contracts, large fines and jail time for individuals.

What Owners and Board Members can Do Today:

  • Call your insurance provider:
    • Do you have a cyber insurance policy?
    • Understand what is covered and make sure that the coverage is appropriate for your business risks.
  • Meet with your technology experts to talk about current protections and risks that they are aware of. Understand where there may be gaps in current protections from a technology perspective and what recommendations the technology experts have to fill those gaps.
  • Consult with legal counsel to identify the laws and regulations that apply to your business related to privacy and cybersecurity compliance.
  • Assemble a cross-functional team of internal and external subject matter experts and professionals who handle critical data of the company to form a privacy steering committee. The Committee’s core responsible should be implementing and maintaining a compliance program that addresses the company’s privacy and cybersecurity risks.

Need conversation starters about privacy and cybersecurity for your board or organization? Contact Partner Allison Cole at aecole@bmdllc.com to discuss ways to address this important topic for your business.


Ohio Board of Pharmacy Update: Key Regulatory Changes and Proposals You Need to Know

The Ohio Board of Pharmacy (BOP) has rescinded certain OAC rules (OAC 4729:5-18-01 through 4729:5-18-06), removing regulations on office-based opioid treatment (OBOT) clinics. The rescissions took effect on June 3, 2024. The BOP also published a new rule, OAC 4729:8-5-01, which sets explicit reporting guidelines for licensed dispensaries and became effective on June 7, 2024.

LGBTQIA+ Patients and Discrimination in Healthcare

In early April, the Kaiser Family Foundation released a study outlining the challenges that LGBT adults face in the United States related to healthcare. According to the study, LGBT patients are “twice as likely as non-LGBT adults to report negative experiences while receiving health care in the last three years, including being treated unfairly or with disrespect (33% v. 15%) or having at least one of several other negative experiences with a provider (61% v. 31%), including a provider assuming something about them without asking, suggesting they were personally to blame for a health problem, ignoring a direct request or question, or refusing to prescribe needed pain medication.”

Ohio Recovery Housing Overhaul: New Standards and Certification Requirements Reshape Sober Living Spaces

Ensuring Fair Access: SB 269 Protects Affordable Medication for Low-Income Patients

SB 269, introduced on December 19, 2023, will ensure that 340B covered entities, including Federally Qualified Health Centers, Ryan White Clinics, disproportionate share hospitals, and Title X clinics, can acquire 340B drugs without facing undue restrictions or discriminatory practices from drug manufacturers and distributors. This protection is crucial for 340B covered entities to continue to provide affordable medications and comprehensive services to low-income patients.

Unveiling Ohio's Pharmacy Board Updates for Distributors, Mobile Clinics, and Controlled Substances

The Ohio Board of Pharmacy will hold a public hearing on May 28, 2024, to discuss several proposed changes and additions to Ohio Administrative Code (OAC). These changes pertain to terminal distributors of dangerous drugs (TDDDs), mobile clinics or medication units, and the classification of controlled substances.